Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Fusion | 11 | 2023 | 429 | 1.900 |
Why?
|
| Lumbar Vertebrae | 7 | 2021 | 354 | 1.660 |
Why?
|
| Neurosurgery | 2 | 2023 | 32 | 1.210 |
Why?
|
| Cervical Vertebrae | 10 | 2023 | 271 | 1.210 |
Why?
|
| Neurosurgical Procedures | 7 | 2020 | 115 | 1.190 |
Why?
|
| Intervertebral Disc | 3 | 2019 | 114 | 1.100 |
Why?
|
| Intervertebral Disc Degeneration | 2 | 2020 | 74 | 1.060 |
Why?
|
| Minimally Invasive Surgical Procedures | 5 | 2021 | 292 | 1.050 |
Why?
|
| Allostasis | 1 | 2023 | 2 | 0.830 |
Why?
|
| Humans | 41 | 2023 | 22823 | 0.700 |
Why?
|
| Spinal Cord Neoplasms | 3 | 2016 | 32 | 0.650 |
Why?
|
| Asymptomatic Diseases | 1 | 2020 | 10 | 0.640 |
Why?
|
| Decompression, Surgical | 3 | 2017 | 117 | 0.610 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 231 | 0.570 |
Why?
|
| Male | 29 | 2023 | 12400 | 0.570 |
Why?
|
| Postoperative Complications | 5 | 2023 | 810 | 0.560 |
Why?
|
| Treatment Outcome | 15 | 2023 | 2934 | 0.560 |
Why?
|
| Female | 27 | 2023 | 12904 | 0.560 |
Why?
|
| Vertebral Artery | 1 | 2017 | 4 | 0.540 |
Why?
|
| Middle Aged | 19 | 2022 | 7873 | 0.510 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 572 | 0.510 |
Why?
|
| Paraparesis | 1 | 2016 | 1 | 0.510 |
Why?
|
| Spondylosis | 2 | 2022 | 26 | 0.510 |
Why?
|
| Scoliosis | 1 | 2017 | 33 | 0.510 |
Why?
|
| Meningeal Neoplasms | 1 | 2016 | 11 | 0.510 |
Why?
|
| Radiculopathy | 1 | 2017 | 41 | 0.500 |
Why?
|
| Multiple Myeloma | 1 | 2016 | 18 | 0.500 |
Why?
|
| Abscess | 1 | 2016 | 26 | 0.490 |
Why?
|
| Epidural Abscess | 1 | 2016 | 3 | 0.490 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2016 | 15 | 0.490 |
Why?
|
| Spinal Cord Diseases | 1 | 2016 | 47 | 0.480 |
Why?
|
| Spinal Cord Compression | 1 | 2016 | 23 | 0.480 |
Why?
|
| Perioperative Care | 1 | 2016 | 42 | 0.480 |
Why?
|
| Adult | 15 | 2023 | 6896 | 0.470 |
Why?
|
| Collagen | 1 | 2015 | 79 | 0.470 |
Why?
|
| Spinal Neoplasms | 2 | 2014 | 34 | 0.450 |
Why?
|
| Spinal Fractures | 2 | 2015 | 43 | 0.440 |
Why?
|
| Head | 1 | 2014 | 17 | 0.430 |
Why?
|
| Professional Competence | 1 | 2014 | 34 | 0.430 |
Why?
|
| General Surgery | 1 | 2014 | 50 | 0.420 |
Why?
|
| Indocyanine Green | 1 | 2013 | 2 | 0.410 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2013 | 3 | 0.410 |
Why?
|
| Angiography | 1 | 2013 | 25 | 0.400 |
Why?
|
| Monitoring, Intraoperative | 1 | 2013 | 34 | 0.400 |
Why?
|
| Thoracic Vertebrae | 2 | 2011 | 88 | 0.390 |
Why?
|
| Ilium | 1 | 2012 | 28 | 0.380 |
Why?
|
| Myenteric Plexus | 3 | 2010 | 4 | 0.370 |
Why?
|
| Osteotomy | 1 | 2012 | 123 | 0.360 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2019 | 858 | 0.360 |
Why?
|
| Chordoma | 1 | 2011 | 8 | 0.360 |
Why?
|
| Internship and Residency | 1 | 2014 | 196 | 0.350 |
Why?
|
| Retrospective Studies | 8 | 2023 | 2976 | 0.340 |
Why?
|
| Axis, Cervical Vertebra | 1 | 2010 | 9 | 0.330 |
Why?
|
| Aged | 12 | 2021 | 7412 | 0.310 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 95 | 0.300 |
Why?
|
| Cauda Equina | 2 | 2006 | 5 | 0.300 |
Why?
|
| Orthopedic Procedures | 1 | 2011 | 225 | 0.290 |
Why?
|
| Aging | 1 | 2015 | 1100 | 0.280 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2021 | 311 | 0.280 |
Why?
|
| Laryngoscopy | 3 | 2017 | 18 | 0.280 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2019 | 63 | 0.270 |
Why?
|
| Neurons | 3 | 2010 | 273 | 0.270 |
Why?
|
| Odontoid Process | 2 | 2017 | 9 | 0.250 |
Why?
|
| Elastic Tissue | 1 | 2006 | 1 | 0.250 |
Why?
|
| Intubation, Intratracheal | 2 | 2017 | 82 | 0.240 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 3717 | 0.240 |
Why?
|
| Diskectomy | 3 | 2022 | 167 | 0.240 |
Why?
|
| Biomarkers | 2 | 2020 | 477 | 0.230 |
Why?
|
| Atlanto-Axial Joint | 2 | 2015 | 11 | 0.230 |
Why?
|
| Age Factors | 2 | 2017 | 633 | 0.210 |
Why?
|
| Colon | 1 | 2004 | 110 | 0.200 |
Why?
|
| Mental Health | 2 | 2021 | 94 | 0.200 |
Why?
|
| Pulmonary Edema | 1 | 2003 | 21 | 0.190 |
Why?
|
| Lordosis | 1 | 2023 | 36 | 0.190 |
Why?
|
| Cadaver | 5 | 2017 | 281 | 0.190 |
Why?
|
| Cohort Studies | 4 | 2021 | 1412 | 0.180 |
Why?
|
| Spinal Curvatures | 1 | 2020 | 13 | 0.170 |
Why?
|
| Motivation | 1 | 2020 | 82 | 0.160 |
Why?
|
| Quality of Life | 2 | 2021 | 559 | 0.160 |
Why?
|
| Spinal Diseases | 1 | 2021 | 106 | 0.160 |
Why?
|
| Collagen Type IV | 1 | 2019 | 4 | 0.150 |
Why?
|
| Collagen Type II | 1 | 2019 | 18 | 0.150 |
Why?
|
| Brain Neoplasms | 2 | 2014 | 71 | 0.150 |
Why?
|
| Motion | 2 | 2016 | 20 | 0.150 |
Why?
|
| Length of Stay | 1 | 2021 | 298 | 0.150 |
Why?
|
| Patient Satisfaction | 1 | 2021 | 255 | 0.150 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 323 | 0.140 |
Why?
|
| Young Adult | 2 | 2016 | 1647 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 210 | 0.140 |
Why?
|
| Esophagus | 2 | 2010 | 53 | 0.140 |
Why?
|
| Range of Motion, Articular | 2 | 2017 | 564 | 0.140 |
Why?
|
| Finite Element Analysis | 1 | 2017 | 22 | 0.140 |
Why?
|
| Spinal Injuries | 1 | 2017 | 23 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2016 | 50 | 0.130 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 309 | 0.120 |
Why?
|
| Fractures, Bone | 1 | 2017 | 70 | 0.120 |
Why?
|
| Neurosurgeons | 1 | 2016 | 6 | 0.120 |
Why?
|
| Cost Savings | 1 | 2016 | 29 | 0.120 |
Why?
|
| Accidental Falls | 1 | 2017 | 104 | 0.120 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 53 | 0.120 |
Why?
|
| Intubation | 1 | 2015 | 5 | 0.120 |
Why?
|
| Recurrence | 1 | 2016 | 268 | 0.120 |
Why?
|
| Larynx | 1 | 2015 | 10 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 28 | 0.120 |
Why?
|
| Organ Transplantation | 1 | 2016 | 32 | 0.120 |
Why?
|
| Hospital Costs | 1 | 2016 | 57 | 0.120 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 45 | 0.120 |
Why?
|
| Prognosis | 2 | 2016 | 714 | 0.120 |
Why?
|
| Atlanto-Occipital Joint | 1 | 2015 | 13 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2016 | 117 | 0.110 |
Why?
|
| Glioma, Subependymal | 1 | 2014 | 6 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2016 | 307 | 0.110 |
Why?
|
| Neural Tube Defects | 2 | 2006 | 6 | 0.110 |
Why?
|
| Neurilemmoma | 1 | 2014 | 12 | 0.110 |
Why?
|
| Hypothermia, Induced | 1 | 2014 | 15 | 0.110 |
Why?
|
| Time Factors | 2 | 2010 | 1258 | 0.110 |
Why?
|
| Medical Errors | 1 | 2014 | 25 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2014 | 80 | 0.110 |
Why?
|
| Papilloma, Choroid Plexus | 1 | 2014 | 1 | 0.110 |
Why?
|
| Cerebellopontine Angle | 1 | 2014 | 2 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2014 | 37 | 0.110 |
Why?
|
| Embolism, Fat | 1 | 2013 | 1 | 0.100 |
Why?
|
| Intracranial Pressure | 1 | 2013 | 10 | 0.100 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2014 | 74 | 0.100 |
Why?
|
| Video Recording | 1 | 2013 | 28 | 0.100 |
Why?
|
| Inflammation | 1 | 2015 | 226 | 0.100 |
Why?
|
| Postoperative Period | 1 | 2014 | 238 | 0.100 |
Why?
|
| Seizures | 1 | 2013 | 62 | 0.100 |
Why?
|
| Brain Diseases | 1 | 2013 | 55 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 1412 | 0.100 |
Why?
|
| Microsurgery | 1 | 2012 | 39 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2012 | 210 | 0.090 |
Why?
|
| Benzophenones | 2 | 2022 | 21 | 0.090 |
Why?
|
| Rats, Wistar | 3 | 2010 | 54 | 0.090 |
Why?
|
| Polymers | 2 | 2022 | 36 | 0.090 |
Why?
|
| Polyethylene Glycols | 2 | 2022 | 35 | 0.090 |
Why?
|
| Joint Instability | 1 | 2015 | 311 | 0.090 |
Why?
|
| Rats | 3 | 2010 | 623 | 0.080 |
Why?
|
| Protein Deficiency | 1 | 2010 | 1 | 0.080 |
Why?
|
| Biomechanical Phenomena | 3 | 2016 | 537 | 0.080 |
Why?
|
| Bone Screws | 1 | 2010 | 127 | 0.080 |
Why?
|
| Pain Measurement | 2 | 2021 | 413 | 0.070 |
Why?
|
| Histocytochemistry | 2 | 2007 | 12 | 0.070 |
Why?
|
| Serratia marcescens | 1 | 2007 | 7 | 0.070 |
Why?
|
| Serratia Infections | 1 | 2007 | 7 | 0.070 |
Why?
|
| Brain Abscess | 1 | 2007 | 4 | 0.070 |
Why?
|
| Diseases in Twins | 1 | 2007 | 8 | 0.070 |
Why?
|
| Diet, Protein-Restricted | 1 | 2007 | 4 | 0.070 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2007 | 6 | 0.070 |
Why?
|
| Craniocerebral Trauma | 2 | 2004 | 5 | 0.060 |
Why?
|
| Laryngoscopes | 2 | 2016 | 5 | 0.060 |
Why?
|
| Adolescent | 1 | 2010 | 1874 | 0.060 |
Why?
|
| Animals | 3 | 2010 | 3255 | 0.060 |
Why?
|
| Colostomy | 1 | 2004 | 2 | 0.060 |
Why?
|
| NAD | 1 | 2004 | 2 | 0.060 |
Why?
|
| NADP | 1 | 2004 | 8 | 0.050 |
Why?
|
| Cell Count | 1 | 2004 | 71 | 0.050 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2004 | 4 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2004 | 228 | 0.050 |
Why?
|
| Child Abuse | 1 | 2004 | 28 | 0.050 |
Why?
|
| Hemophilia A | 1 | 2004 | 47 | 0.050 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2003 | 4 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2003 | 19 | 0.050 |
Why?
|
| Headache | 1 | 2003 | 36 | 0.050 |
Why?
|
| Neck | 1 | 2023 | 23 | 0.050 |
Why?
|
| Acute Disease | 1 | 2003 | 162 | 0.050 |
Why?
|
| Ketones | 1 | 2022 | 19 | 0.050 |
Why?
|
| Critical Care | 1 | 2003 | 97 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2021 | 107 | 0.040 |
Why?
|
| Convalescence | 1 | 2020 | 5 | 0.040 |
Why?
|
| Minimal Clinically Important Difference | 1 | 2021 | 83 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2020 | 34 | 0.040 |
Why?
|
| Leg | 1 | 2020 | 40 | 0.040 |
Why?
|
| Allografts | 1 | 2021 | 147 | 0.040 |
Why?
|
| Back Pain | 1 | 2020 | 52 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 69 | 0.040 |
Why?
|
| Spine | 1 | 2020 | 98 | 0.040 |
Why?
|
| Acetylcholinesterase | 2 | 2010 | 2 | 0.040 |
Why?
|
| NADPH Dehydrogenase | 2 | 2010 | 5 | 0.040 |
Why?
|
| Pain | 1 | 2020 | 326 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2017 | 8 | 0.030 |
Why?
|
| Pregnancy | 2 | 2010 | 324 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 1487 | 0.030 |
Why?
|
| Supine Position | 1 | 2016 | 15 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2016 | 32 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 591 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 523 | 0.030 |
Why?
|
| Syndrome | 1 | 2013 | 66 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2013 | 50 | 0.030 |
Why?
|
| Femoral Fractures | 1 | 2013 | 31 | 0.030 |
Why?
|
| Disease Management | 1 | 2013 | 98 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2010 | 26 | 0.020 |
Why?
|
| Thienamycins | 1 | 2007 | 6 | 0.020 |
Why?
|
| Amikacin | 1 | 2007 | 5 | 0.020 |
Why?
|
| Dihydrolipoamide Dehydrogenase | 1 | 2007 | 1 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 21 | 0.020 |
Why?
|
| Weaning | 1 | 2007 | 6 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 350 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2007 | 534 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 362 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 312 | 0.010 |
Why?
|
| Sex Factors | 1 | 2004 | 384 | 0.010 |
Why?
|
| Infant | 1 | 2004 | 478 | 0.010 |
Why?
|